Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FX005 for Pain in Osteoarthritis of the Knee
NCT01291914Phase 2Completed
- Sponsor
- Pacira BioSciences
- Start
- Dec 2010
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 2, randomised, double-blind trial of FX005 in osteoarthritis (OA) (3 arms), sponsored by Pacira BioSciences. Primary endpoint: Change from baseline in the WOMAC A score (pain subscale) at 4 weeks. Started Dec 2010; status: completed.
02
Drugs
FX005
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01291914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01291914.